Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Shahzad Akbar Khan"'
Autor:
Buhari Yusuf, Shuai Wang, Md Shah Alam, Jingran Zhang, Zhiyong Liu, Ziwen Lu, Jie Ding, Gift Chiwala, Yamin Gao, Cuiting Fang, Shahzad Akbar Khan, Xirong Tian, Md Mahmudul Islam, H. M. Adnan Hameed, Dmitry A. Maslov, Nanshan Zhong, Jinxing Hu, Tianyu Zhang
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 10 (2024)
ABSTRACT The increasing clinical significance of Mycobacterium abscessus is owed to its innate high-level, broad-spectrum resistance to antibiotics and therefore rapidly evolves as an important human pathogen. This warrants the identification of nove
Externí odkaz:
https://doaj.org/article/2fa01b2e3deb4ca0a395ca048b52a533
Autor:
Faisal Rasool, Zaheer Ahmed Nizamani, Khawaja Shafique Ahmad, Fahmida Parveen, Shahzad Akbar Khan, Naveed Sabir
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Kashmir Himalaya hosts the most diverse and rich flora in the world, which serves as grazing land for millions of small ruminants in the area. While most plant species are beneficial, some can be poisonous, causing economic losses and ani
Externí odkaz:
https://doaj.org/article/842b0080c6564f89a388492ec8d98352
Autor:
Md Mahmudul Islam, Md Shah Alam, Zhiyong Liu, Mst Sumaia Khatun, Buhari Yusuf, H. M. Adnan Hameed, Xirong Tian, Chiranjibi Chhotaray, Rajesh Basnet, Haftay Abraha, Xiaofan Zhang, Shahzad Akbar Khan, Cuiting Fang, Chunyu Li, Sohel Hasan, Shouyong Tan, Nanshan Zhong, Jinxing Hu, Tianyu Zhang
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
Clofazimine (CFZ) and bedaquiline (BDQ) are currently used for the treatment of multidrug-resistant (MDR) Mycobacterium tuberculosis (Mtb) strains. In recent years, adding CFZ and BDQ to tuberculosis (TB) drug regimens against MDR Mtb strains has sig
Externí odkaz:
https://doaj.org/article/53aceef45fd5414d90a3e7b3c19004b3
Autor:
Lei Zhang, Jiaqing Yang, Changchun Lai, Li Wan, Shilong Xiong, Weiya Kong, Zijian Liu, Pei Yu, Mingxiao Chen, Weikang Mai, Shahzad Akbar Khan, Min Deng, Lu Chen, Yu Lei, Qiang Zhou, Nan Yu, Pingchao Li, Zheng Chen, Tianxing Ji
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
BackgroundA third mRNA vaccine booster is recommended to improve immunity against SARS-CoV-2 in kidney transplant recipients (KTRs). However, the immunity against SARS-CoV-2 Ancestral strain and Delta and Omicron variants elicited by the third dose o
Externí odkaz:
https://doaj.org/article/32a129c951624d58965e193f5b300380
Autor:
Faisal Rasool, Zaheer Ahmed Nizamani, Khawaja Shafique Ahmad, Fahmida Parveen, Shahzad Akbar Khan, Naveed Sabir
Publikováno v:
PLoS ONE, Vol 17, Iss 5 (2022)
Poisonous plants cause tremendous economic losses to the livestock industry. These economic losses are deterioration in their health, decreased productivity, deformed offspring, and reduced longevity. The current study is the first comprehensive repo
Externí odkaz:
https://doaj.org/article/fc73c305154e4a199ce4516384161c9e
Autor:
Gift Chiwala, Zhiyong Liu, Julius N. Mugweru, Bangxing Wang, Shahzad Akbar Khan, Petuel Ndip Ndip Bate, Buhari Yusuf, H.M. Adnan Hameed, Cuiting Fang, Yaoju Tan, Ping Guan, Jinxing Hu, Shouyong Tan, Jianxiong Liu, Nanshan Zhong, Tianyu Zhang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112047- (2021)
Drug-resistant tuberculosis (DR-TB) poses a new threat to global health; to improve the treatment outcome, therapeutic vaccines are considered the best chemotherapy adjuvants. Unfortunately, there is no therapeutic vaccine approved against DR-TB. Our
Externí odkaz:
https://doaj.org/article/e81490eaa1994df8be39238fad6500c3
Autor:
Wei Yu, Gift Chiwala, Yamin Gao, Zhiyong Liu, Sanjeep Sapkota, Zhili Lu, Lingmin Guo, Shahzad Akbar Khan, Nanshan Zhong, Tianyu Zhang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 131, Iss , Pp 110782- (2020)
Multidrug-resistant tuberculosis (MDR-TB) remains a serious public health threat worldwide. To date, the anti-TB activity of TB47 (T), an imidazopyridine amide class of antibiotics targeting QcrB in the electron transport chain, has not been systemat
Externí odkaz:
https://doaj.org/article/30e771fad8bf497cb9466fc1b38c7b92
Autor:
Baseer Ahmad, Quratulain Hanif, Xubiao Wei, Lulu Zhang, Naveed Sabir, Zhongxuan Li, Junhao Cheng, Shahzad Akbar Khan, Abdul Basit, Muhammad Shahid, Amin ur Rehman, Dayong Si, Rijun Zhang
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
CATH-2TP5 is a linear cationic hybrid peptide, consequent from naturally occurring antimicrobial peptide (AMPs) Cathelicidin-2 (CATH-2) and Immunomodulatory peptide Thymopentin (TP5) having dynamic and potent anti-inflammatory activities without hemo
Externí odkaz:
https://doaj.org/article/2e3e7d8f586e414db205ae8b57219dde
Autor:
FeiFei Ma, Cheng Zhi, Minling Wang, Tao Li, Shahzad Akbar Khan, Zhaoen Ma, Zhiliang Jing, Chen Bo, Qiang Zhou, Shaomei Xia, Shiwen Huang, Sicong Huang, Zhiquan Zhang, Hongyun Jia, Xiaogang Cui, Mingze Yao, Tianxing Ji
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 125, Iss , Pp 109905- (2020)
Background: Nasopharyngeal carcinoma (NPC) is common in Southern China. The molecular mechanism underlying NPC genesis and progression has been comprehensively investigated, but the key gene (s) or pathway (s) pertaining to NPC are unidentified. Meth
Externí odkaz:
https://doaj.org/article/84583199a65d46eba1fa938839b0fb09
Autor:
Baseer Ahmad, Zhongxuan Li, Quratulain Hanif, Qingyong Hu, Xubiao Wei, Lulu Zhang, Shahzad Akbar Khan, Maierhaba Aihemaiti, Huma Gulzar, Muhammad Shahid, Dayong Si, Rijun Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
DEFB-TP5 is a novel auspicious health-beneficial peptide derivative from two naturally occurring peptides, β-Defensin (DEFB) and thymopentin (TP5), and shows strong anti-inflammatory activity and binds to LPS without cytotoxicity and hemolytic effec
Externí odkaz:
https://doaj.org/article/914ff5c5eb8c47a8af35938440b8ed7a